Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients
This study aimed at determining the relationship between baseline cystatin C levels and coronavirus disease 2019 (COVID-19) and investigating the potential prognostic value of serum cystatin C in adult patients with COVID-19. 481 patients with COVID-19 were consecutively included in this study from...
Saved in:
Main Authors: | Dan Chen, Wenwu Sun, Jia Li, Bohua Wei, Wei Liu, Xiaopin Wang, Fan Song, Liangkai Chen, Junhui Yang, Li Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/3764515 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associations of Serum Cystatin C, DNAm Cystatin C, Renal Function, and Mortality in U.S. Adults
by: Yu-Wei Fang, et al.
Published: (2024-12-01) -
Prognostic value of serum cystatin C in patients with sepsis
by: Chunfang Hu, et al.
Published: (2023-07-01) -
Use of Cystatin C Biomarker in Patients with Possible Renal Failure
by: Alexander Benavides Couto, et al.
Published: (2019-11-01) -
Hypoglycemia and hospital mortality in critically ill patients
by: Hsuan-Fan Yeh, et al.
Published: (2025-01-01) -
Risk Predictors for Mortality in Inpatients with Cancer and Coronavirus Disease 2019 during the Omicron Wave
by: Kuan-Yu Chen, et al.
Published: (2023-10-01)